READER 1 | ||||
 Overall detected hyperenhanced lesions in patients showing global LGE (n = 33) | ||||
  Breath-hold | n = 126/561 (22.5%) detected hyperenhanced lesions | P < .0001 | ||
  Free-breathing | n = 153/561 (27.3%) detected hyperenhanced lesions | |||
 LGE localization | Subendocardial | Mid-myocardial | Subepicardial | Transmural |
  Breath-hold | 24/126 (19.1%) | 25/126 (19.8%) | 21/126 (16.7%) | 56/126 (44.4%) |
  Free-breathing | 31/153 (20.3%) | 29/153 (19.0%) | 32/153 (20.9%) | 61/153 (39.9%) |
 LGE transmural extent | 1–25% | 26–50% | 51–75% | 76–100% |
  Breath-hold | 16/126 (12.7%) | 25/126 (19.8%) | 25/126 (19.8%) | 60/126 (47.6%) |
  Free-breathing | 29/153 (18.9%) | 32/153 (20.9%) | 27/153 (17.6%) | 65/153 (42.5%) |
READER 2 | ||||
 Overall detected hyperenhanced lesions in patients showing global LGE (n = 33) | ||||
  Breath-hold | n = 138/561 (24.6%) detected hyperenhanced lesions | P < .0001 | ||
  Free-breathing | n = 163/561 (29.1%) detected hyperenhanced lesions | |||
 LGE localization | Subendocardial | Mid-myocardial | Subepicardial | Transmural |
  Breath-hold | 33/138 (23.9%) | 24/138 (17.4%) | 27/138 (19.6%) | 54/138 (39.1%) |
  Free-breathing | 39/163 (23.9%) | 31/163 (19.0%) | 38/163 (23.3%) | 55/163 (33.7%) |
 LGE transmural extent | 1–25% | 26–50% | 51–75% | 76–100% |
  Breath-hold | 23/138 (16.7%) | 28/138 (20.3%) | 31/138 (22.5%) | 56/138 (40.6%) |
  Free-breathing | 35/163 (21.5%) | 38/163 (23.3%) | 31/163 (19.0%) | 59/163 (36.2%) |
AVERAGED for both readers | ||||
 Overall detected hyperenhanced lesions in patients showing global LGE (n = 33) | ||||
  Breath-hold | n = 132/561 (23.5%) detected hyperenhanced lesions | P < .0001 | ||
  Free-breathing | n = 158/561 (28.2%) detected hyperenhanced lesions | |||
 LGE localization | Subendocardial | Mid-myocardial | Subepicardial | Transmural |
  Breath-hold | 28.5/132 (21.6%) | 24.5/132 (18.6%) | 24/132 (18.2%) | 55/132 (41.7%) |
  Free-breathing | 35/158 (22.2%) | 30/158 (19.0%) | 35/158 (22.2%) | 58/158 (36.7%) |
 LGE transmural extent | 1–25% | 26–50% | 51–75% | 76–100% |
  Breath-hold | 19.5/132 (14.8%) | 26.5/132 (20.1%) | 28/132 (21.2%) | 58/132 (43.9%) |
  Free-breathing | 32/158 (20.2%) | 35/158 (22.2%) | 29/158 (18.4%) | 62/158 (39.2%) |